Ritter Pharmaceuticals, Inc.
(NASDAQ: RTTR) The 36 Months beta value for RTTR stocks is at 0.99, while of the analysts out of 0 who provided ratings for Ritter Pharmaceuticals, Inc.
stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $7.00 which is $6.79 above current price. RTTR currently has a short float of 4.22% and public float of 24.25 M with average trading volume
of 4.07M shares.